Are ‘same but not the same’ generic antidepressants adding to the complex issues of antidepressant harm and dependence? An emerging danger to the health of patients, why might those taking generic antidepressants be particularly at risk? Lack of innovation meaning fewer new drugs and patents expiring on blockbuster drugs means the generic drug market is growing rapidly. Generic drugs must demonstrate bioequivalence to the brand-name original, however, two pills with the same